Elevated Basal Insulin Secretion in Type 2 Diabetes Caused by Reduced Plasma Membrane Cholesterol.
about
Butyrate reduces high-fat diet-induced metabolic alterations, hepatic steatosis and pancreatic beta cell and intestinal barrier dysfunctions in prediabetic mice.HDL cholesterol efflux normalised to apoA-I is associated with future development of type 2 diabetes: from the CORDIOPREV trial.Cytokine-mediated changes in K+ channel activity promotes an adaptive Ca2+ response that sustains β-cell insulin secretion during inflammation.
P2860
Elevated Basal Insulin Secretion in Type 2 Diabetes Caused by Reduced Plasma Membrane Cholesterol.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Elevated Basal Insulin Secreti ...... d Plasma Membrane Cholesterol.
@en
Elevated Basal Insulin Secreti ...... d Plasma Membrane Cholesterol.
@nl
type
label
Elevated Basal Insulin Secreti ...... d Plasma Membrane Cholesterol.
@en
Elevated Basal Insulin Secreti ...... d Plasma Membrane Cholesterol.
@nl
prefLabel
Elevated Basal Insulin Secreti ...... d Plasma Membrane Cholesterol.
@en
Elevated Basal Insulin Secreti ...... d Plasma Membrane Cholesterol.
@nl
P2093
P2860
P356
P1476
Elevated Basal Insulin Secreti ...... d Plasma Membrane Cholesterol.
@en
P2093
Abdulla S Kazim
Clemens Lewold
Erik Renström
Johan Helgeson
Pawel Buda
Satadal Barik
Stefan Wennmalm
Thomas M Reinbothe
Vini Nagaraj
P2860
P304
P356
10.1210/ME.2016-1023
P50
P577
2016-08-17T00:00:00Z